Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: a randomized controlled trial

CONCLUSION: A short-term treatment with dapagliflozin may increase CRT as compared with equivalent glycemic control with glibenclamide.PMID:34537385 | DOI:10.1016/j.diabet.2021.101280

Source: Diabetes and Metabolism - September 19, 2021 Category: Endocrinology Authors: Vicente Hidalgo Rodrigues Fernandes Fernando R P Chaves Alexandre A S Soares Ikaro Breder Sheila T Kimura-Medorima Daniel B Munhoz Riobaldo M R Cintra Jessica Cunha Breder Joaquim Barreto Wilson Nadruz Luiz Sergio F Carvalho Thiago Quinaglia Carlos E L Ar Source Type: research